8-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 

Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) December 15, 2015
 
 
HOLOGIC, INC.
(Exact Name of Registrant as Specified in Its Charter)

 
DELAWARE
(State or Other Jurisdiction of Incorporation)
 
 
 
 
1-36214
 
04-2902449
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
 
 
 
250 Campus Drive, Marlborough, MA
 
01730
(Address of Principal Executive Offices)
 
(Zip Code)
 
(508) 263-2900
(Registrant’s Telephone Number, Including Area Code)
 
 
(Former Name or Former Address, if Changed Since Last Report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


(e)    Compensatory Arrangements of Certain Officers
Amended and Restated Deferred Equity Plan
On December 15, 2015, the Compensation Committee of the Board of Directors of Hologic, Inc. (the “Company”) approved and adopted an amendment and restatement of the Hologic, Inc. Deferred Equity Plan (the “DEP”). The DEP was amended and restated to permit participants to defer existing grants of restricted stock units and performance share units, subject to compliance with Section 409(A) of the U.S. Internal Revenue Code of 1986, as amended, and to incorporate several administrative clarifications to plan language.

The above description of the DEP does not purport to be complete and is qualified in its entirety by reference to the DEP, a copy of which is attached to this report as Exhibit 10.1, and is incorporated herein in its entirety by reference.


Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit
Number
 
Description

10.1

 

Hologic, Inc. Amended and Restated Deferred Equity Plan






SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
Date: December 16, 2015
 
HOLOGIC, INC.
 
 
 
 
 
By:
 
 /s/ John M. Griffin

 
 
 
 
John M. Griffin
 
 
 
 
General Counsel
 



EXHIBIT INDEX

Exhibit No.    Exhibit Name_______________________________________________

10.1
Hologic, Inc. Amended and Restated Deferred Equity Plan